Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (24386)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2014 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Elpek G&. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol 2014; 20(23): 7260-7276 [PMID: 24966597 DOI: 10.3748/wjg.v20.i23.7260] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i23/7260.htm |
| Number | Citing Articles |
| 1 |
Jack P. Carson, Mark W. Robinson, Grant A. Ramm, Geoffrey N. Gobert. RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation. Molecular Biology Reports 2021; 48(12): 7677 doi: 10.1007/s11033-021-06774-3
|
| 2 |
Omar Ramos-Lopez, Erika Martinez-Lopez, Sonia Roman, Nora A Fierro, Arturo Panduro. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World Journal of Gastroenterology 2015; 21(41): 11552-11566 doi: 10.3748/wjg.v21.i41.11552
|
| 3 |
Chao Wu, Weiyang Chen, Hanyan Ding, Dong Li, Guanghua Wen, Chong Zhang, Wanpeng Lu, Ming Chen, Yan Yang. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro. Life Sciences 2019; 239: 116881 doi: 10.1016/j.lfs.2019.116881
|
| 4 |
N. Luo, J. Li, Y. Wei, J. Lu, R. Dong. Hepatic Stellate Cell: A Double-Edged Sword in the Liver. Physiological Research 2021; (6): 821 doi: 10.33549/physiolres.934755
|
| 5 |
Sushila Maharjan, Diana Bonilla, Yu Shrike Zhang. 3D Bioprinting and Nanotechnology in Tissue Engineering and Regenerative Medicine. 2022; : 459 doi: 10.1016/B978-0-12-824552-1.00010-4
|
| 6 |
Zhiping Zeng, Yujing Wu, Yirong Cao, Ziying Yuan, Yuanqing Zhang, David Y. Zhang, Daisuke Hasegawa, Scott L. Friedman, Jinsheng Guo. Slit2-Robo2 signaling modulates the fibrogenic activity and migration of hepatic stellate cells. Life Sciences 2018; 203: 39 doi: 10.1016/j.lfs.2018.04.017
|
| 7 |
Fei Liu, Changfeng Sun, Yuanfang Chen, Fei Du, Yuxiang Yang, Gang Wu. Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00032
|
| 8 |
Ming Xiang, Tingting Liu, Cheng Tian, Kun Ma, Jing Gou, Rongrong Huang, Senlin Li, Qing Li, Chuanrui Xu, Lei Li, Chih-Hao Lee, Yonghui Zhang. Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway. Pharmacological Research 2022; 177: 106092 doi: 10.1016/j.phrs.2022.106092
|
| 9 |
Shanjun Tao, Renjie Duan, Tong Xu, Jiao Hong, Wenjie Gu, Aiqin Lin, Likai Lian, Haoyu Huang, Jiangtao Lu, Tiechen Li. Salvianolic acid B inhibits the progression of liver fibrosis in rats via modulation of the Hedgehog signaling pathway. Experimental and Therapeutic Medicine 2021; 23(2) doi: 10.3892/etm.2021.11039
|
| 10 |
Tao Guo, Zu-long Liu, Qiang Zhao, Zhi-min Zhao, Cheng-hai Liu. A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo
. Acta Pharmacologica Sinica 2018; 39(9): 1483 doi: 10.1038/aps.2017.175
|
| 11 |
Rocio I.R. Macias, Maria J. Monte, Maria A. Serrano, Jesús M. González-Santiago, Isabel Martín-Arribas, André L. Simão, Rui E. Castro, Javier González-Gallego, José L. Mauriz, Jose J.G. Marin. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics. Aging 2021; 13(19): 23416 doi: 10.18632/aging.203620
|
| 12 |
Reham M. Dawood, Mai Abd el-Meguid, Marwa K. Ibrahim, Noha G. Bader El Din, Ahmed Barakat, Khaled El-Wakeel, Mohamed Darwish Ahmed Abd Alla, George Y. Wu, Mostafa K. El Awady. Dysregulation of fibrosis related genes in HCV induced liver disease. Gene 2018; 664: 58 doi: 10.1016/j.gene.2018.04.032
|
| 13 |
Emily Truong, Mazen Noureddin. The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease. Clinics in Liver Disease 2022; 26(2): 213 doi: 10.1016/j.cld.2022.01.008
|
| 14 |
Shenghao Li, Liyuan Hao, Fei Yu, Na Li, Jiali Deng, Junli Zhang, Shuai Xiong, Xiaoyu Hu. Capsaicin: a spicy way in liver disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1451084
|
| 15 |
Mattareeyapar Phaosri, Salinee Jantrapirom, Mingkwan Na Takuathung, Noppamas Soonthornchareonnon, Seewaboon Sireeratawong, Pensiri Buacheen, Pornsiri Pitchakarn, Wutigri Nimlamool, Saranyapin Potikanond. Salacia chinensis L. Stem Extract Exerts Antifibrotic Effects on Human Hepatic Stellate Cells through the Inhibition of the TGF-β1-Induced SMAD2/3 Signaling Pathway. International Journal of Molecular Sciences 2019; 20(24): 6314 doi: 10.3390/ijms20246314
|
| 16 |
E. V. Mahiliavets, P. V. Garelik, S. M. Zimatkin, S. S. Anufrik, N. I. Prokopchik. THE MORPHOLOGY OF THE LIVER IN CCl<sub>4</sub>-INDUCED CIRRHOSIS UNDER THE INFLUENCE OF PHOTODYNAMIC THERAPY. Health and Ecology Issues 2015; (1): 71 doi: 10.51523/2708-6011.2015-12-1-14
|
| 17 |
Bisma Rauff, Mark W Douglas. Role of Fibrogenic and Inflammatory Cytokines in HCV-Induced Fibrosis. Future Virology 2015; 10(12): 1307 doi: 10.2217/fvl.15.102
|
| 18 |
Yan Yu, Zhiyong Xu, Changbo Ou, Qiuxia Wang, Yanhong Zhang, Feng Guo, Pei Gao, Jinyou Ma. The effect of ghrelin on the fibrosis of chicken bursa of fabricius infected with infectious bursal disease virus. General and Comparative Endocrinology 2021; 303: 113705 doi: 10.1016/j.ygcen.2020.113705
|
| 19 |
Jie Han, Yaping He, Hui Zhao, Xiaowei Xu. Hypoxia inducible factor‐1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway. Journal of Cellular Biochemistry 2019; 120(9): 14735 doi: 10.1002/jcb.28734
|
| 20 |
Donatas Jocius, Donatas Vajauskas, Artūras Samuilis, Kipras Mikelis, Skirmante Jokubauskiene, Kestutis Strupas, Algirdas E. Tamosiunas. Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study. Medicina 2023; 59(3): 479 doi: 10.3390/medicina59030479
|
| 21 |
Rifu Wang, Yuxin Shi, Yonglin Lv, Changqing Xie, Yanjia Hu. The novel insights of epithelial-derived exosomes in various fibrotic diseases. Biomedicine & Pharmacotherapy 2024; 174: 116591 doi: 10.1016/j.biopha.2024.116591
|
| 22 |
Yufeng Jiang, Chao Wu, Alex Boye, Jiajun Wu, Jiyu Wang, Xiaochuan Yang, Yan Yang. MAPK inhibitors modulate Smad2/3/4 complex cyto-nuclear translocation in myofibroblasts via Imp7/8 mediation. Molecular and Cellular Biochemistry 2015; 406(1-2): 255 doi: 10.1007/s11010-015-2443-x
|
| 23 |
Qi Cheng, Chen Li, Cheng-fang Yang, Yu-juan Zhong, Dan Wu, Lin Shi, Li Chen, Yong-wen Li, Li Li. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways. Chemico-Biological Interactions 2019; 299: 131 doi: 10.1016/j.cbi.2018.12.006
|
| 24 |
Zihui Tang, Xiaojuan Li, Le Tian, Yuhao Sun, Xinyan Zhu, Fei Liu. Mesoporous polydopamine based biominetic nanodrug ameliorates liver fibrosis via antioxidation and TGF-β/SMADS pathway. International Journal of Biological Macromolecules 2023; 248: 125906 doi: 10.1016/j.ijbiomac.2023.125906
|
| 25 |
Shenzong Rao, Jie Xiang, Jingsong Huang, Shangang Zhang, Min Zhang, Haoran Sun, Jian Li. PRC1 promotes GLI1-dependent osteopontin expression in association with the Wnt/β-catenin signaling pathway and aggravates liver fibrosis. Cell & Bioscience 2019; 9(1) doi: 10.1186/s13578-019-0363-2
|
| 26 |
Xueyan Chen, Chuanbo Ding, Wencong Liu, Xinglong Liu, Yingchun Zhao, Yinan Zheng, Ling Dong, Sadia Khatoon, Mingqian Hao, Xiaojuan Peng, Yue Zhang, Huiying Chen. Abscisic acid ameliorates oxidative stress, inflammation, and apoptosis in thioacetamide-induced hepatic fibrosis by regulating the NF-кB signaling pathway in mice. European Journal of Pharmacology 2021; 891: 173652 doi: 10.1016/j.ejphar.2020.173652
|
| 27 |
Archittapon Nokkeaw, Pannathon Thamjamrassri, Pisit Tangkijvanich, Chaiyaboot Ariyachet. Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis. Cells 2023; 12(3): 378 doi: 10.3390/cells12030378
|
| 28 |
Xin Han, YanLing Wu, Qiao Yang, Gang Cao. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacology & Therapeutics 2021; 222: 107791 doi: 10.1016/j.pharmthera.2020.107791
|
| 29 |
Viola Tamasi, Krisztina Németh, Miklós Csala. Role of Extracellular Vesicles in Liver Diseases. Life 2023; 13(5): 1117 doi: 10.3390/life13051117
|
| 30 |
Tongxi Zhuang, Xinyi Gu, Nian Zhou, Lili Ding, Li Yang, Mingmei Zhou. Hepatoprotection and hepatotoxicity of Chinese herb Rhubarb (Dahuang): How to properly control the “General (Jiang Jun)” in Chinese medical herb. Biomedicine & Pharmacotherapy 2020; 127: 110224 doi: 10.1016/j.biopha.2020.110224
|
| 31 |
Yanlan Chen, Junyuan Huang, Huaixu Wang, Haohui Cui, Zizhao Liang, Darong Huang, Xinyu Deng, Bing Du, Pan Li. Polysaccharides from Sacha Inchi shell reduces renal fibrosis in mice by modulating the TGF-β1/Smad pathway and intestinal microbiota. International Journal of Biological Macromolecules 2024; 280: 136039 doi: 10.1016/j.ijbiomac.2024.136039
|
| 32 |
Heba M. Adel Abou Zaghla, Aziza Ahmed El Sebai, Ossama Ashraf Ahmed, Ayat Fawzy Ahmed, Azza Abdel Rahman Saab. Growth differentiation factor 15: an emerging diagnostic biomarker of liver fibrosis in chronic hepatitis C patients. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00075-x
|
| 33 |
Omar Nunez Lopez, Fredrick J. Bohanon, Xiaofu Wang, Na Ye, Tiziana Corsello, Yesenia Rojas-Khalil, Haijun Chen, Haiying Chen, Jia Zhou, Ravi S. Radhakrishnan. STAT3 inhibition suppresses hepatic stellate cell fibrogenesis: HJC0123, a potential therapeutic agent for liver fibrosis. RSC Advances 2016; 6(102): 100652 doi: 10.1039/C6RA17459K
|
| 34 |
Li Li, Lei Zhang, Xiongqi Zhao, Jun Cao, Jingfeng Li, Guang Chu. Downregulation of miR‑152 contributes to the progression of liver fibrosis via targeting Gli3 in�vivo and in�vitro. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7595
|
| 35 |
Li-Jun Song, Xu-Ren Yin, Sha-Sha Mu, Jia-Huang Li, Hong Gao, Ying Zhang, Pan-Pan Dong, Cong-Jin Mei, Zi-Chun Hua. The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.570524
|
| 36 |
Biyu Hou, Yuerong Zhao, Guifen Qiang, Xiuying Yang, Chunyang Xu, Xi Chen, Chenge Liu, Xiaobo Wang, Li Zhang, Guanhua Du, Giuseppe Valacchi. Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF‐β Signaling Pathway Activation in Type 2 Diabetic Rats. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/4545321
|
| 37 |
Mayuko Ichimura-Shimizu, Yosuke Tsuchiyama, Yuki Morimoto, Minoru Matsumoto, Tomoko Kobayashi, Satoshi Sumida, Takumi Kakimoto, Takeshi Oya, Hirohisa Ogawa, Michiko Yamashita, Satoru Matsuda, Katsuhisa Omagari, Shu Taira, Koichi Tsuneyama. A Novel Mouse Model of Nonalcoholic Steatohepatitis Suggests that Liver Fibrosis Initiates around Lipid-Laden Macrophages. The American Journal of Pathology 2022; 192(1): 31 doi: 10.1016/j.ajpath.2021.10.002
|
| 38 |
Zhifa Wang, Xiaoke Yang, Siyu Gui, Fan Yang, Zhuo Cao, Rong Cheng, Xiaowei Xia, Chuanying Li. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.779606
|
| 39 |
Heba A. Hassan, Mahitab M. Nageeb, Heba Osama Mohammed, Walaa Samy, Amal Fawzy, Rofaida Afifi, Noha A.T. Abbas. Dapagliflozin dampens liver fibrosis induced by common bile duct ligation in rats associated with the augmentation of the hepatic Sirt1/AMPK/PGC1α/FoxO1 axis. Toxicology and Applied Pharmacology 2024; 489: 116991 doi: 10.1016/j.taap.2024.116991
|
| 40 |
Veruska Cintia Alexandrino de Souza, Thiago Almeida Pereira, Valéria Wanderley Teixeira, Helotonio Carvalho, Maria Carolina Accioly Brelaz de Castro, Carolline Guimarães D’assunção, Andréia Ferreira de Barros, Camila Lima Carvalho, Virgínia Maria Barros de Lorena, Vláudia Maria Assis Costa, Álvaro Aguiar Coelho Teixeira, Regina Celia Bressan Queiroz Figueiredo, Sheilla Andrade de Oliveira. Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress. World Journal of Gastroenterology 2017; 23(28): 5146-5157 doi: 10.3748/wjg.v23.i28.5146
|
| 41 |
Li-ya Mu, Shu-qin Li, Li-xin Tang, Rui Li. Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis. Clinics 2021; 76: e2409 doi: 10.6061/clinics/2021/e2409
|
| 42 |
Eszter Regős, Hadeer Hesham Abdelfattah, Andrea Reszegi, László Szilák, Klára Werling, Gábor Szabó, András Kiss, Zsuzsa Schaff, Ilona Kovalszky, Kornélia Baghy. Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14. Matrix Biology 2018; : 474 doi: 10.1016/j.matbio.2018.02.008
|
| 43 |
Hao Ouyang, Hui Miao, Zhen Li, Duan Wu, Si-Cheng Gao, Yao-Yao Dai, Xiao-Di Gao, Hai-Sheng Chai, Wei-Ye Hu, Jun-Feng Zhu. Yinhuang granule alleviates carbon tetrachloride-induced liver fibrosis in mice and its mechanism. World Journal of Hepatology 2024; 16(2): 264-278 doi: 10.4254/wjh.v16.i2.264
Abstract(237) |
Core Tip(226) |
Full Article(HTML)(1052)
|
Full Article with Cover (PDF)-24205K(68)
|
Full Article (Word)-7208K(8)
|
Audio-108K(1)
|
Peer-Review Report-199K(30)
|
Answering Reviewers-148K(31)
|
Full Article (PDF)-23695K(65)
|
Full Article (XML)-113K(31)
|
Times Cited (0)
|
Total Visits (3560)
|
Open
|
| 44 |
Chong-Yang Zhang, Wei-Gang Yuan, Pei He, Jia-Hui Lei, Chun-Xu Wang. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World Journal of Gastroenterology 2016; 22(48): 10512-10522 doi: 10.3748/wjg.v22.i48.10512
|
| 45 |
Dorothy Rosique-Oramas, Moises Martinez-Castillo, Carolina Guzman, José Luis Pérez Hernández, Jacqueline Cordova-Gallardo, Luis Very-Pineda, Fatima Higuera-De La Tijera, Daniel Santana-Vargas, Eduardo Montalvo-Jave, Francisco Sanchez-Avila, Paula Cordero Perez, Linda Muñoz-Espinosa, David Kershenobich, Gabriela Gutiérrez-Reyes. Liver Cirrhosis - Debates and Current Challenges. 2019; doi: 10.5772/intechopen.84351
|
| 46 |
Shuang Hu, Su-wen Li, Qi Yan, Xiang-peng Hu, Liang-yun Li, Hong Zhou, Lin-xin Pan, Jun Li, Chuan-pu Shen, Tao Xu. Natural products, extracts and formulations comprehensive therapy for the improvement of motor function in alcoholic liver disease. Pharmacological Research 2019; 150: 104501 doi: 10.1016/j.phrs.2019.104501
|
| 47 |
Eun Ju Lee, Injoo Hwang, Ji Yeon Lee, Jong Nam Park, Keun Cheon Kim, Irene Kim, Dodam Moon, Hyomin Park, Seo-Yeon Lee, Hong Sug Kim, Dae Won Jun, Sung-Hye Park, Hyo-Soo Kim. Hepatic stellate cell–specific knockout of transcriptional intermediary factor 1γ aggravates liver fibrosis. Journal of Experimental Medicine 2020; 217(6) doi: 10.1084/jem.20190402
|
| 48 |
Yani Liu, Jianhong Wu, Zhongfang Li, Ying Luo, Fandian Zeng, Shaojun Shi. Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study. European Journal of Drug Metabolism and Pharmacokinetics 2017; 42(1): 37 doi: 10.1007/s13318-015-0316-z
|
| 49 |
Hyuk Moon, Kyungjoo Cho, Sunyeong Shin, Do Young Kim, Kwang-Hyub Han, Simon Weonsang Ro. High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway. International Journal of Molecular Sciences 2019; 20(3): 581 doi: 10.3390/ijms20030581
|
| 50 |
Mohamed E. Shaker, Nada H. Eisa, Abdelaziz Elgaml, Ahmed El-Mesery, Mohamed El-Shafey, Mohamed El-Dosoky, Mohammed El-Mowafy, Mohamed El-Mesery. Ingestion of mannose ameliorates thioacetamide-induced intrahepatic oxidative stress, inflammation and fibrosis in rats. Life Sciences 2021; 286: 120040 doi: 10.1016/j.lfs.2021.120040
|
| 51 |
Shao-hua Luan, Yu-qing Yang, Man-ping Ye, Hui Liu, Qiu-fan Rao, Jin-ling Kong, Fan-rong Wu. ASIC1a promotes hepatic stellate cell activation through the exosomal miR-301a-3p/BTG1 pathway. International Journal of Biological Macromolecules 2022; 211: 128 doi: 10.1016/j.ijbiomac.2022.05.041
|
| 52 |
Bertille Elodie E. Edinga, Jean Joel Bigna, Jobert Richie Nansseu, Adrienne Y. Tchapmi, Stéphane Fargeon M. Mbouna, Suzanne Belinga, Oudou Njoya, Vicky Jocelyne Ama-Moor, Richard Njouom. Simple noninvasive tests for liver fibrosis diagnosis in sub-Saharan African adults with chronic viral hepatitis B or C: A cross sectional study in Cameroon. Clinica Chimica Acta 2022; 536: 56 doi: 10.1016/j.cca.2022.09.009
|
| 53 |
Logan S. Dean, Dominic C. Chow, Lishomwa C. Ndhlovu, William A. Boisvert, Sandra P. Chang, Cecilia M. Shikuma, Juwon Park. Characterization of Circulating Fibrocytes in People Living with HIV on Stable Antiretroviral Therapy. ImmunoHorizons 2022; 6(11): 760 doi: 10.4049/immunohorizons.2200085
|
| 54 |
Tiago L. Duarte, Carolina Caldas, Ana G. Santos, Sandro Silva-Gomes, Andreia Santos-Gonçalves, Maria João Martins, Graça Porto, José Manuel Lopes. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis. Redox Biology 2017; 11: 157 doi: 10.1016/j.redox.2016.11.013
|
| 55 |
Zhen Li, Qian Ding, Li-Ping Ling, Ying Wu, Dong-Xiao Meng, Xiao Li, Chun-Qing Zhang. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells <i>in vivo</i> and <i>in vitro</i> by activating AMP-activated protein kinase. World Journal of Gastroenterology 2018; 24(7): 819-832 doi: 10.3748/wjg.v24.i7.819
|
| 56 |
Minghe Wang, Xuejing Wang, Yanqi Wang, Yikuo Gai, Jingran Ye, Xinyan Xu, Xue You. Advances in the study of the mechanism of action of miR‑22 in liver lesions (Review). Oncology Letters 2024; 28(5) doi: 10.3892/ol.2024.14674
|
| 57 |
Isabel Fabregat, Daniel Caballero-Díaz. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00357
|
| 58 |
Reham M. Dawood, Mai A. El-Meguid, Ghada Maher Salum, Mostafa K. El Awady. Key Players of Hepatic Fibrosis. Journal of Interferon & Cytokine Research 2020; 40(10): 472 doi: 10.1089/jir.2020.0059
|
| 59 |
R. Mihaylov, B. Pencheva, D. Stoeva, A. Ruseva. Non-invasive Diagnostics of Liver Fibrosis. Acta Medica Bulgarica 2017; 44(1): 50 doi: 10.1515/amb-2017-0009
|
| 60 |
Qin Yu, Xiaoqin Xiong, Lei Zhao, Tingting Xu, Qianhua Wang. Antifibrotic effects of specific siRNA targeting connective tissue growth factor delivered by polyethyleneimine‑functionalized magnetic iron oxide nanoparticles on LX‑2 cells. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10834
|
| 61 |
Na-Hyun Kim, Jeong-Doo Heo, Tae Bum Kim, Jung-Rae Rho, Min Hye Yang, Eun Ju Jeong. Protective Effects of Ethyl Acetate Soluble Fraction of <i>Limonium tetragonum</i> on Diethylnitrosamine-Induced Liver Fibrosis in Rats. Biological & Pharmaceutical Bulletin 2016; 39(6): 1022 doi: 10.1248/bpb.b15-01047
|
| 62 |
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
|
| 63 |
Valentina Masola, Giovanni Gambaro, Maurizio Onisto. Heparanase. Advances in Experimental Medicine and Biology 2020; 1221: 669 doi: 10.1007/978-3-030-34521-1_27
|
| 64 |
Syed Yeasin Arafat, Mohammad Nayeem, Sharfiat Jahan, Zarifa Karim, Hasan Mahmud Reza, Md Hemayet Hossain, Mohammad Shohel, Md Ashraful Alam. Ellagic acid rich Momordica charantia fruit pulp supplementation prevented oxidative stress, fibrosis and inflammation in liver of alloxan induced diabetic rats. Oriental Pharmacy and Experimental Medicine 2016; 16(4): 267 doi: 10.1007/s13596-016-0242-x
|
| 65 |
Cai Zhang, Xing Tian, Ke Zhang, Guo-Yu Li, Hang-Yu Wang, Jin-Hui Wang. Protective effects of <i>Foeniculum vulgare</i> root bark extract against carbon tetrachloride-induced hepatic fibrosis in mice. World Journal of Gastroenterology 2017; 23(31): 5722-5731 doi: 10.3748/wjg.v23.i31.5722
|
| 66 |
Jana Enderes, Jessica Teschke, Steffen Manekeller, Tim O. Vilz, Jörg C. Kalff, Tim R. Glowka. Chronic Liver Disease Increases Mortality Following Pancreatoduodenectomy. Journal of Clinical Medicine 2021; 10(11): 2521 doi: 10.3390/jcm10112521
|
| 67 |
Vladislav V. Tsukanov, Ekaterina G. Gorchilova, Oksana A. Kolenchukova, Ivan I. Gvozdev, Andrei A. Savchenko, Eduard V. Kasparov, Aleksandr V. Vasyutin, Juliia L. Tonkikh, Aleksandr G. Borisov, Olga S. Rzhavicheva. Functional activity of blood neutrophilic granulocytes in patients with opisthorchiasis, depending on the severity of liver fibrosis. Terapevticheskii arkhiv 2021; 93(11): 1271 doi: 10.26442/00403660.2021.11.201165
|
| 68 |
Maria Francesca Secchi, Marika Crescenzi, Valentina Masola, Francesco Paolo Russo, Annarosa Floreani, Maurizio Onisto. Heparanase and macrophage interplay in the onset of liver fibrosis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14946-0
|
| 69 |
Yongxin Wang, Bin Chen, Chengcheng Xiao, Jiang Yu, Xiangyang Bu, Fengxing Jiang, Weijie Ding, Zhong Ge. Effect of miR-183-5p on Cholestatic Liver Fibrosis by Regulating Fork Head Box Protein O1 Expression. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.737313
|
| 70 |
Timea Csak, Shashi Bala, Dora Lippai, Karen Kodys, Donna Catalano, Arvin Iracheta-Vellve, Gyongyi Szabo, Rafael Aldabe. MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis. PLOS ONE 2015; 10(6): e0129251 doi: 10.1371/journal.pone.0129251
|
| 71 |
Radan Bruha, Libor Vitek, Vaclav Smid. Osteopontin – A potential biomarker of advanced liver disease. Annals of Hepatology 2020; 19(4): 344 doi: 10.1016/j.aohep.2020.01.001
|
| 72 |
Dong Won Baek, Hee Jeong Cho, Ju-Hyung Kim, Jae Sook Ahn, Hyeoung-Joon Kim, Sung Nam Lim, Jun Won Cheong, Sung-Yong Kim, Ho Sup Lee, Jong Ho Won, Ho-Young Yhim, Sang Kyun Sohn, Joon Ho Moon. Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD. Cell Transplantation 2022; 31 doi: 10.1177/09636897221113789
|
| 73 |
Shukai Zhan, Na Li, Caiguang Liu, Ren Mao, Dongxuan Wu, Tong Li, Minhu Chen, Xiaojun Zhuang, Zhirong Zeng. Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.694967
|
| 74 |
Subin Jeong, Jisue Kim, Hye Mi Jeon, Kyunghee Kim, Gun Yong Sung. Development of an Aged Full-Thickness Skin Model Using Flexible Skin-on-a-Chip Subjected to Mechanical Stimulus Reflecting the Circadian Rhythm. International Journal of Molecular Sciences 2021; 22(23): 12788 doi: 10.3390/ijms222312788
|
| 75 |
Cornel Balta, Hildegard Herman, Alina Ciceu, Bianca Mladin, Marcel Rosu, Alciona Sasu, Victor Eduard Peteu, Sorina Nicoleta Voicu, Mihaela Balas, Mihaela Gherghiceanu, Anca Dinischiotu, Neli Kinga Olah, Anca Hermenean. Phytochemical Profiling and Anti-Fibrotic Activities of the Gemmotherapy Bud Extract of Corylus avellana in a Model of Liver Fibrosis on Diabetic Mice. Biomedicines 2023; 11(6): 1771 doi: 10.3390/biomedicines11061771
|
| 76 |
Lei Yang, Yaru Liu, Yingyin Sun, Cheng Huang, Jun Li, Yuanyuan Wang. New advances of DNA/RNA methylation modification in liver fibrosis. Cellular Signalling 2022; 92: 110224 doi: 10.1016/j.cellsig.2021.110224
|
| 77 |
Patric Schyman, Richard L. Printz, Shanea K. Estes, Kelli L. Boyd, Masakazu Shiota, Anders Wallqvist. Identification of the Toxicity Pathways Associated With Thioacetamide-Induced Injuries in Rat Liver and Kidney. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01272
|
| 78 |
Reza Afarin, Hossein Babaahmadi Rezaei, Hamid Yaghooti, Narges Mohammadtaghvaei. Fibroblast Growth Factor 21 Reduces Cholesterol-Induced Hepatic Fibrogenesis by Inhibiting TGF-β/Smad3C Signaling Pathway in LX2 Cells. Hepatitis Monthly 2021; 21(4) doi: 10.5812/hepatmon.113321
|
| 79 |
Rong Wu, Shu Dong, Fei-Fei Cai, Xiao-Le Chen, Meng-Die Yang, Ping Liu, Shi-Bing Su. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis. Molecules 2019; 24(2): 338 doi: 10.3390/molecules24020338
|
| 80 |
Xiaoli Rong, Yanyan Yang, Guokun Zhang, Haiying Zhang, Chunyi Li, Yimin Wang. Antler stem cells as a novel stem cell source for reducing liver fibrosis. Cell and Tissue Research 2020; 379(1): 195 doi: 10.1007/s00441-019-03081-z
|
| 81 |
Bedair Dewidar, Christoph Meyer, Steven Dooley, and Nadja Meindl-Beinker. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019. Cells 2019; 8(11): 1419 doi: 10.3390/cells8111419
|
| 82 |
Xiuqing Li, Hui Zhang, Lijuan Pan, Haiou Zou, Xiaonan Miao, Jing Cheng, Youshan Wu. Puerarin alleviates liver fibrosis via inhibition of the ERK1/2 signaling pathway in thioacetamide‑induced hepatic fibrosis in rats. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7534
|
| 83 |
Büsra Öztürk Akcora, Alexandros Vassilios Gabriël, Ana Ortiz‐Perez, Ruchi Bansal. Pharmacological inhibition of STAT3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cells. FASEB BioAdvances 2020; 2(2): 77 doi: 10.1096/fba.2019-00070
|
| 84 |
A. G. Lishnevska, M. D. Chemych. CORRELATIONS BETWEEN CLINICAL, HEMATOLOGICAL, BIOCHEMICAL AND INTEGRATIVE INDICATORS AND THE DEGREE OF FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C. Hepatology and Gastroenterology 2020; 4(1): 45 doi: 10.25298/2616-5546-2020-4-1-45-54
|
| 85 |
Mohamed A. Morsy, Anroop B. Nair. Prevention of rat liver fibrosis by selective targeting of hepatic stellate cells using hesperidin carriers. International Journal of Pharmaceutics 2018; 552(1-2): 241 doi: 10.1016/j.ijpharm.2018.10.003
|
| 86 |
Diana K. Ghobrial, Nefertiti El-Nikhely, Eman Sheta, Hanan M. Ragab, Sherif A. F. Rostom, Hesham Saeed, Ahmed Wahid. The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl4-Induced Liver Fibrosis in Rats. Antioxidants 2023; 12(3): 637 doi: 10.3390/antiox12030637
|
| 87 |
Farooq Riaz, Dongmin Li. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis. Current Gene Therapy 2019; 19(5): 305 doi: 10.2174/1566523219666191107113046
|
| 88 |
Xiaoyu Wang, Lihong Mao, Chaoqun Li, Yangyang Hui, Zihan Yu, Mingyu Sun, Yifan Li, Gaoyue Guo, Wanting Yang, Binxin Cui, Xiaofei Fan, Chao Sun. The potential role of FNDC5/irisin in various liver diseases: awakening the sleeping beauties. Expert Reviews in Molecular Medicine 2022; 24 doi: 10.1017/erm.2022.19
|
| 89 |
Juan Xiao, Chunmei Jin, Zhixue Liu, Shujing Guo, Xiaochuan Zhang, Xin Zhou, Xue Wu. The design, synthesis, and biological evaluation of novel YC-1 derivatives as potent anti-hepatic fibrosis agents. Organic & Biomolecular Chemistry 2015; 13(26): 7257 doi: 10.1039/C5OB00710K
|
| 90 |
Yehong Liu, Puye Yang, Na Chen, Shumei Lin, Min Liu. Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis. International Journal of Molecular Medicine 2016; 38(4): 1093 doi: 10.3892/ijmm.2016.2716
|
| 91 |
Barbara Schreier, Alexander Zipprich, Henriette Uhlenhaut, Michael Gekle. Mineralocorticoid receptors in non‐alcoholic fatty liver disease. British Journal of Pharmacology 2022; 179(13): 3165 doi: 10.1111/bph.15784
|
| 92 |
Hui Miao, Yi Zhang, Zhenlin Huang, Bin Lu, Lili Ji. Lonicera japonica Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice: Molecular Mechanisms of Action. The American Journal of Chinese Medicine 2019; 47(02): 351 doi: 10.1142/S0192415X19500174
|
| 93 |
Mengfan Liu, Xueyang Sun, Boya Chen, Rongchen Dai, Zhichao Xi, Hongxi Xu. Insights into Manganese Superoxide Dismutase and Human Diseases. International Journal of Molecular Sciences 2022; 23(24): 15893 doi: 10.3390/ijms232415893
|
| 94 |
Xiangyun Tan, Xinyu Huang, Zhuhang Lu, Liang Chen, Junjie Hu, Xianxiang Tian, Zhenpeng Qiu. The essential effect of mTORC1-dependent lipophagy in non-alcoholic fatty liver disease. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1124003
|
| 95 |
Shanshan Zhu, Tao Wang, Fei Luo, Huawen Li, Qing Jia, Taiping He, Hongfu Wu, Tangbin Zou. Astaxanthin inhibits proliferation and induces apoptosis of LX‑2 cells by regulating the miR‑29b/Bcl‑2 pathway. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10025
|
| 96 |
Mishghan Zehra, James C. Curry, Sneha S. Pillai, Hari Vishal Lakhani, Cory E. Edwards, Komal Sodhi. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis. International Journal of Molecular Sciences 2020; 21(13): 4737 doi: 10.3390/ijms21134737
|
| 97 |
Esperanza Mata-Martínez, María Guadalupe Ramírez-Ledesma, Genaro Vázquez-Victorio, Rolando Hernández-Muñoz, Mauricio Díaz-Muñoz, Francisco G. Vázquez-Cuevas. Purinergic Signaling in Non-Parenchymal Liver Cells. International Journal of Molecular Sciences 2024; 25(17): 9447 doi: 10.3390/ijms25179447
|
| 98 |
Yanfei Du, Jun Ma, Yu Fan, Xinyu Wang, Shuzhan Zheng, Jian Feng, Jiafu Li, Zhongcai Fan, Guang Li, Qiang Ye, Rosalba Parenti. Naringenin: A Promising Therapeutic Agent against Organ Fibrosis. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/1210675
|
| 99 |
Hui Miao, Hao Ouyang, Qian Guo, Mengjuan Wei, Bin Lu, Guoyin Kai, Lili Ji. Chlorogenic acid alleviated liver fibrosis in methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice and its mechanism. The Journal of Nutritional Biochemistry 2022; 106: 109020 doi: 10.1016/j.jnutbio.2022.109020
|
| 100 |
Federico Lucantoni, Andreu Martínez‐Cerezuela, Aleksandra Gruevska, Ángela B Moragrega, Víctor M Víctor, Juan V Esplugues, Ana Blas‐García, Nadezda Apostolova. Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?. The Journal of Pathology 2021; 254(3): 216 doi: 10.1002/path.5678
|
| 101 |
Michał Kukla, Marek Waluga, Michał Żorniak, Agnieszka Berdowska, Piotr Wosiewicz, Tomasz Sawczyn, Rafał J Bułdak, Marek Ochman, Katarzyna Ziora, Tadeusz Krzemiński, Marek Hartleb. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis. World Journal of Gastroenterology 2017; 23(14): 2613-2624 doi: 10.3748/wjg.v23.i14.2613
|
| 102 |
Nilofer Sayed, Amit Khurana, Mohd Aslam Saifi, Mandip Singh, Chandraiah Godugu. Withaferin A reverses bile duct ligation‐induced liver fibrosis by modulating extracellular matrix deposition: Role of LOXL2/Snail1, vimentin, and NFκB signaling. BioFactors 2019; 45(6): 959 doi: 10.1002/biof.1546
|
| 103 |
Hong-Jing Zhu, Sheng-Yu Zhou, Yang Qu, Ying-Ying Sun, Ke-Jia Zhang, Shu-Yan Pang, Yi Yang, Zhen-Ni Guo. Prognostic Value of Fibrosis-4 in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis. Clinical Interventions in Aging 2024; : 1663 doi: 10.2147/CIA.S469899
|
| 104 |
Calen A. Steiner, Peter D. R. Higgins. Fibrostenotic Inflammatory Bowel Disease. 2018; : 347 doi: 10.1007/978-3-319-90578-5_23
|
| 105 |
Erika Ramos‐Tovar, Laura D. Buendia‐Montaño, Silvia Galindo‐Gómez, Erika Hernández‐Aquino, Víctor Tsutsumi, Pablo Muriel. Stevia prevents experimental cirrhosis by reducing hepatic myofibroblasts and modulating molecular profibrotic pathways. Hepatology Research 2019; 49(2): 212 doi: 10.1111/hepr.13275
|
| 106 |
De Ji, Qi Zhao, Yuwen Qin, Huangjin Tong, Qiaohan Wang, Mengting Yu, Chunqin Mao, Tulin Lu, Jinchun Qiu, Chengxi Jiang. Germacrone improves liver fibrosis by regulating the PI3K/AKT/mTOR signalling pathway. Cell Biology International 2021; 45(9): 1866 doi: 10.1002/cbin.11607
|
| 107 |
Michaela Jeong, Sumin Shin, Gyeongseok Lee, Yeji Lee, Seo Bhin Park, Jisoo Kang, Young-Sun Lee, Wonhyo Seo, Hyukjin Lee. Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis. Journal of Controlled Release 2024; 374: 337 doi: 10.1016/j.jconrel.2024.08.012
|
| 108 |
Pramod Patidar, Nik Hirani, Shreya Bharti, Mirza S Baig. Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review. International Immunopharmacology 2024; 141: 112938 doi: 10.1016/j.intimp.2024.112938
|
| 109 |
Ikuo Nakamura, Faizal Z. Asumda, Catherine D. Moser, Yoo Na N. Kang, Jin-Ping Lai, Lewis R. Roberts. Sulfatase-2 Regulates Liver Fibrosis through the TGF-β Signaling Pathway. Cancers 2021; 13(21): 5279 doi: 10.3390/cancers13215279
|
| 110 |
Dong Ji, Guo‐Feng Chen, Jin‐Cheng Wang, Li‐Hua Cao, Fengmin Lu, Xiao‐Xin Mu, Xiao‐Yu Zhang, Xiao‐Jie Lu. Identification of TAF1, HNF4A, and CALM2 as potential therapeutic target genes for liver fibrosis. Journal of Cellular Physiology 2019; 234(6): 9045 doi: 10.1002/jcp.27579
|
| 111 |
Joel T. Haas, Sven Francque, Bart Staels. Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease. Annual Review of Physiology 2016; 78(1): 181 doi: 10.1146/annurev-physiol-021115-105331
|
| 112 |
Joseph George, Mutsumi Tsuchishima, Mikihiro Tsutsumi. Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis. Cell Death & Disease 2019; 10(1) doi: 10.1038/s41419-018-1272-8
|
| 113 |
Hang Lyu, Huihui Wang, Lu Li, Jiayu Zhu, Feng Chen, Yannan Chen, Cuijie Liu, Jingqi Fu, Bei Yang, Qiang Zhang, Yuanyuan Xu, Jingbo Pi. Hepatocyte-specific deficiency of Nrf2 exacerbates carbon tetrachloride-induced liver fibrosis via aggravated hepatocyte injury and subsequent inflammatory and fibrogenic responses. Free Radical Biology and Medicine 2020; 150: 136 doi: 10.1016/j.freeradbiomed.2020.02.015
|
| 114 |
Liyue Zhou, Qiangwei Liang, Yifan Li, Yongjing Cao, Juan Li, Jiayu Yang, Jinxia Liu, Jiawei Bi, Yanhua Liu. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy. Acta Biomaterialia 2022; 152: 235 doi: 10.1016/j.actbio.2022.08.065
|
| 115 |
Naglaa A. Bayomy, Gehan M. Soliman, Eman Z. Abdelaziz. Effect of Potassium Bromate on the Liver of Adult Male Albino Rat and A Possible Protective Role of Vitamin C: Histological, Immunohistochemical, and Biochemical Study. The Anatomical Record 2016; 299(9): 1256 doi: 10.1002/ar.23386
|
| 116 |
Weiwei Li, Mingjuan Deng, Jiahui Gong, Xiaoying Zhang, Shaoyang Ge, Liang Zhao. Sodium Acetate Inhibit TGF-β1-Induced Activation of Hepatic Stellate Cells by Restoring AMPK or c-Jun Signaling. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.729583
|
| 117 |
Julia Maroto-García, Ana Moreno Álvarez, María P. Sanz de Pedro, Antonio Buño-Soto, Álvaro González. Serum biomarkers for liver fibrosis assessment. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2024; 5(2): 115 doi: 10.1515/almed-2023-0081
|
| 118 |
Jack P. Carson, Mark W. Robinson, Grant A. Ramm, Geoffrey N. Gobert. Synthetic peptides derived from the Schistosoma mansoni secretory protein Sm16 induce contrasting responses in hepatic stellate cells. Experimental Parasitology 2022; : 108255 doi: 10.1016/j.exppara.2022.108255
|
| 119 |
Xiankui Li, Lei Wang, Cai Chen. Effects of exogenous thymosin β4 on carbon tetrachloride-induced liver injury and fibrosis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06318-5
|
| 120 |
Zongqiang Hu, Li Li, Jianghua Ran, Guang Chu, Hongqiang Gao, Licheng Guo, Jiapeng Chen. miR-125b acts as anti-fibrotic therapeutic target through regulating Gli3 in vivo and in vitro. Annals of Hepatology 2019; 18(6): 825 doi: 10.1016/j.aohep.2019.06.016
|
| 121 |
Mengjuan Xuan, Xinyu Gu, Huiwu Xing. Multi-omic analysis identifies the molecular mechanism of hepatocellular carcinoma with cirrhosis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-75609-5
|
| 122 |
Silvia Sovaila, Adrian Purcarea, Dan Gheonea, Sanziana Ionescu, Tudorel Ciurea. Cellular Interactions in the Human Fatty Liver. Journal of Medicine and Life 2019; 12(4): 338 doi: 10.25122/jml-2019-1010
|
| 123 |
Yusheng Zhao, Hui Kong, Yuru Li, Yafang Zhao, Yue Zhang, Yan Zhao, Huihua Qu.
Inhibitory effects of
Curcumae Radix carbonisata
-based carbon dots against liver fibrosis induced by carbon tetrachloride in mice
. Artificial Cells, Nanomedicine, and Biotechnology 2024; 52(1): 23 doi: 10.1080/21691401.2023.2239522
|
| 124 |
Verónica Miguel, Santiago Lamas. Oxidative Stress. 2020; : 779 doi: 10.1016/B978-0-12-818606-0.00037-7
|
| 125 |
Long Cui, Yu-Jing Tan, Shi-Qi Xu, Bo-Feng Qin, Meng-Xue Xiu, Xue Zhang, Li-Qiang Shi, Hai-Ming Sun, Jian Song. Ginsenoside Rd, a natural production for attenuating fibrogenesis and inflammation in hepatic fibrosis by regulating the ERRα-mediated P2X7r pathway. Food & Function 2023; 14(12): 5606 doi: 10.1039/D3FO01315D
|
| 126 |
Anna Blázovics. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021; : 57 doi: 10.1016/B978-0-12-816488-4.00010-3
|
| 127 |
Mengyao Ma, Wenhua Xie, Xi Li. Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis. International Journal of General Medicine 2021; : 3163 doi: 10.2147/IJGM.S317785
|
| 128 |
Lifeng Qin, Jinmei Qin, Xiumei Zhen, Qian Yang, Liyi Huang. Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis：A study in vitro and in vivo. Biomedicine & Pharmacotherapy 2018; 101: 599 doi: 10.1016/j.biopha.2018.02.091
|
| 129 |
Xiuting He, Ting Liu, Rui Zhang, Xu Li, Nadeem Sheikh. Associations between Extracellular Matrix Protein 1 Gene Polymorphism and Progression of Liver Disease. Genetics Research 2022; 2022: 1 doi: 10.1155/2022/9304264
|
| 130 |
Ching-Ju Huang, Shao-Jung Hsu, Yi-Chiung Hsu, Liang-Kun Chen, Chuan Li, Hui-Chun Huang, Yu-Hsiang Lee. Synthesis, characterization, and biological verification of asialoglycoprotein receptor-targeted lipopolysaccharide-encapsulated PLGA nanoparticles for the establishment of a liver fibrosis animal model. Biomaterials Science 2023; 11(19): 6650 doi: 10.1039/D3BM01058A
|
| 131 |
Ali Tavakoli Pirzaman, Ali Alishah, Bahareh Babajani, Pouyan Ebrahimi, Seyyed Ali Sheikhi, Farhad Moosaei, Amirhossein Salarfar, Shahrbanoo Doostmohamadian, Sohrab Kazemi. The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241239188
|
| 132 |
Omar A. Mesarwi, Mi-Kyung Shin, Shannon Bevans-Fonti, Christina Schlesinger, Janet Shaw, Vsevolod Y. Polotsky, Matias A Avila. Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease. PLOS ONE 2016; 11(12): e0168572 doi: 10.1371/journal.pone.0168572
|
| 133 |
YA-LEI ZHAO, RONG-TAO ZHU, YU-LING SUN. Epithelial-mesenchymal transition in liver fibrosis. Biomedical Reports 2016; 4(3): 269 doi: 10.3892/br.2016.578
|
| 134 |
Shan Yu, Matthew Ericson, Andrea Fanjul, Derek M. Erion, Maria Paraskevopoulou, Erin N. Smith, Banumathi Cole, Ryan Feaver, Corine Holub, Narender Gavva, Shane R. Horman, Jie Huang. Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells. ACS Chemical Biology 2022; 17(4): 918 doi: 10.1021/acschembio.2c00006
|
| 135 |
Marwan SM Al-Nimer. Is COVID-19-induced liver injury different from other RNA viruses?. World Journal of Meta-Analysis 2021; 9(2): 108-127 doi: 10.13105/wjma.v9.i2.108
|
| 136 |
Nidhi Sharma, Taslim B. Shaikh, Abhisheik Eedara, Madhusudhana Kuncha, Ramakrishna Sistla, Sai Balaji Andugulapati. Dehydrozingerone ameliorates thioacetamide-induced liver fibrosis via inhibition of hepatic stellate cells activation through modulation of the MAPK pathway. European Journal of Pharmacology 2022; 937: 175366 doi: 10.1016/j.ejphar.2022.175366
|
| 137 |
Nan Zhang, Meilan Xue, Ting Sun, Jia Yang, Zhongqian Pei, Kunpeng Qin. Fucoidan as an Autophagy Regulator: Mechanisms and Therapeutic Potentials for Cancer and Other Diseases. Nutrition and Cancer 2022; 74(5): 1568 doi: 10.1080/01635581.2021.1973045
|
| 138 |
Xi Chen, Xin Zhang, Ming Du, Chengyan Dong, Li Cao, Rucheng Wei, Changping Liu, Wei Zhai, Bo Wang, Jun Xin. In vivo preclinical PET/CT imaging of carbon-11-labeled aminoglycerol probe for the diagnosis of liver fibrosis. Annals of Nuclear Medicine 2019; 33(11): 806 doi: 10.1007/s12149-019-01391-4
|
| 139 |
Mei-Ling Tsai, Siao-Ping Tsai, Chi-Tang Ho. Tetrahydrocurcumin attenuates carbon tetrachloride-induced hepatic fibrogenesis by inhibiting the activation and autophagy of hepatic stellate cells. Journal of Functional Foods 2017; 36: 418 doi: 10.1016/j.jff.2017.07.031
|
| 140 |
Jinze Li, Yi Xiang, Jiahao Han, Youfang Gao, Ruiying Wang, Zihe Dong, Huihui Chen, Ruixia Gao, Chuan Liu, Gao-Jun Teng, Xiaolong Qi. Retinopathy as a predictive indicator for significant hepatic fibrosis according to T2DM status: A cross-sectional study based on the national health and nutrition examination survey data. Annals of Hepatology 2024; 29(4): 101478 doi: 10.1016/j.aohep.2024.101478
|
| 141 |
Yu-Feng Liu, Guo-Chao Niu, Chen-Yang Li, Jin-Bo Guo, Jia Song, Hui Li, Xiao-Lan Zhang. Mechanism of Ulcerative Colitis-Aggravated Liver Fibrosis: The Activation of Hepatic Stellate Cells and TLR4 Signaling Through Gut-Liver Axis. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.695019
|
| 142 |
Xi-ji Qin, Jia-xiang Zhang, Rui-lan Wang. Exosomes As Mediators and Biomarkers in Fibrosis. Biomarkers in Medicine 2020; 14(8): 697 doi: 10.2217/bmm-2019-0368
|
| 143 |
Cyriac Abby Philips, Philip Augustine, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Gopakumar C. Valiathan, Solomon K. John. Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, ‘Inside Any Deep Asking Is the Answering’. Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00034
|
| 144 |
Ralf Weiskirchen, Abdo Mahli, Sabine Weiskirchen, Claus Hellerbrand. The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. Frontiers in Physiology 2015; 6 doi: 10.3389/fphys.2015.00140
|
| 145 |
Qi Su, Sun Y. Kim, Funmi Adewale, Ye Zhou, Christina Aldler, Min Ni, Yi Wei, Michael E. Burczynski, Gurinder S. Atwal, Mark W. Sleeman, Andrew J. Murphy, Yurong Xin, Xiping Cheng. Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. iScience 2021; 24(11): 103233 doi: 10.1016/j.isci.2021.103233
|
| 146 |
Natascha Roehlen, Emilie Crouchet, Thomas F. Baumert. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020; 9(4): 875 doi: 10.3390/cells9040875
|
| 147 |
Narges Mohammadtaghvaei, Reza Afarin, Fatemeh Mavalizadeh, Elham Shakerian, Samaneh Salehipour Bavarsad, Ghorban Mohammadzadeh. Effect of Quercetin on the Expression of NOXs and P-Smad3C in TGF-Β-Activated Hepatic Stellate Cell Line LX-2. Hepatitis Monthly 2021; 21(6) doi: 10.5812/hepatmon.116875
|
| 148 |
Yunyang Bao, Yudong Pang, Sheng Tang, Tianyun Niu, Zhihao Guo, Hongwei He, Yinghong Li, Danqing Song. 12N-Substituted Matrinol Derivatives Inhibited the Expression of Fibrogenic Genes via Repressing Integrin/FAK/PI3K/Akt Pathway in Hepatic Stellate Cells. Molecules 2019; 24(20): 3748 doi: 10.3390/molecules24203748
|
| 149 |
Liyue Zhou, Yifan Li, Qiangwei Liang, Jinxia Liu, Yanhua Liu. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review. Journal of Drug Targeting 2022; 30(6): 577 doi: 10.1080/1061186X.2022.2044485
|
| 150 |
Yu Miao, Yanling Wu, Yingjin Jin, Mengze Lei, Jixing Nan, Xue Wu. Benzoquinone derivatives with antioxidant activity inhibit activated hepatic stellate cells and attenuate liver fibrosis in TAA-induced mice. Chemico-Biological Interactions 2020; 317: 108945 doi: 10.1016/j.cbi.2020.108945
|
| 151 |
Cositha Santhakumar, Edward J. Gane, Ken Liu, Geoffrey W. McCaughan. Current perspectives on the tumor microenvironment in hepatocellular carcinoma. Hepatology International 2020; 14(6): 947 doi: 10.1007/s12072-020-10104-3
|
| 152 |
Michal Safran, Rula Masoud, Maya Sultan, Irena Tachlytski, Chofit Chai Gadot, Ron Pery, Nora Balint-Lahat, Orit Pappo, Nahum Buzaglo, Ziv Ben-Ari. Extracellular Vesicular Transmission of miR-423-5p from HepG2 Cells Inhibits the Differentiation of Hepatic Stellate Cells. Cells 2022; 11(10): 1715 doi: 10.3390/cells11101715
|
| 153 |
Terunao Iwanaga, Tetsuhiro Chiba, Masato Nakamura, Tatsuya Kaneko, Junjie Ao, Na Qiang, Yaojia Ma, Jiaqi Zhang, Tadayoshi Kogure, Sae Yumita, Takamasa Ishino, Keita Ogawa, Motoyasu Kan, Miyuki Nakagawa, Kisako Fujiwara, Naoto Fujita, Takafumi Sakuma, Hiroaki Kanzaki, Keisuke Koroki, Yuko Kusakabe, Masanori Inoue, Kazufumi Kobayashi, Naoya Kanogawa, Soichiro Kiyono, Takayuki Kondo, Ryo Nakagawa, Sadahisa Ogasawara, Shingo Nakamoto, Ryosuke Muroyama, Jun Kato, Tatsuo Kanda, Hitoshi Maruyama, Naoya Mimura, Takuya Honda, Toshihiko Murayama, Hiroyuki Nakamura, Naoya Kato. Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells. Biochemical and Biophysical Research Communications 2023; 642: 192 doi: 10.1016/j.bbrc.2022.12.025
|
| 154 |
Francesco STALLA, Angelo ARMANDI, Chiara MARINONI, Sharmila FAGOONEE, Rinaldo PELLICANO, Gian P. CAVIGLIA. Chronic hepatitis B virus infection and fibrosis: novel non-invasive approaches for diagnosis and risk stratification. Minerva Gastroenterology 2022; 68(3) doi: 10.23736/S2724-5985.21.02911-9
|
| 155 |
Yuping Wang, Zhichao Liu, Wen Zou, Huixiao Hong, Hong Fang, Weida Tong. Molecular Regulation of Mirnas and Potential Biomarkers in the Progression of Hepatic Steatosis to NASH. Biomarkers in Medicine 2015; 9(11): 1189 doi: 10.2217/bmm.15.70
|
| 156 |
Cho-Rong Bae, Jun Hino, Hiroshi Hosoda, Mikiya Miyazato, Kenji Kangawa. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis. Life Sciences 2018; 209: 349 doi: 10.1016/j.lfs.2018.08.031
|
| 157 |
E. Velázquez-Miranda, M. Díaz-Muñoz, F. G. Vázquez-Cuevas. Purinergic signaling in hepatic disease. Purinergic Signalling 2019; 15(4): 477 doi: 10.1007/s11302-019-09680-3
|
| 158 |
Rimpy Diwan, Samantha Lynn Gaytan, Himanshu Narendrakumar Bhatt, Jacqueline Pena-Zacarias, Md Nurunnabi. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities. Drug Delivery and Translational Research 2024; 14(10): 2743 doi: 10.1007/s13346-024-01551-8
|
| 159 |
Islam M. Ibrahim, Hanan S. Althagafy, Esraa K. Abd-alhameed, W.S. Al-Thubiani, Emad H.M. Hassanein. Promising hepatoprotective effects of lycopene in different liver diseases. Life Sciences 2022; 310: 121131 doi: 10.1016/j.lfs.2022.121131
|
| 160 |
Qing-Qing Liu, Jing Chen, Tao Ma, Wei Huang, Cui-Hua Lu. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59698-w
|
| 161 |
Gerhard Rogler. Fibrostenotic Inflammatory Bowel Disease. 2018; : 295 doi: 10.1007/978-3-319-90578-5_20
|
| 162 |
Alya Elzoheiry, Esraa Ayad, Nahed Omar, Kadry Elbakry, Ayman Hyder. Anti-liver fibrosis activity of curcumin/chitosan-coated green silver nanoparticles. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23276-9
|
| 163 |
Hsiao-Hsuan Wang, Jian-Hao Huang, Min-Hao Sue, Wei-Chih Ho, Yu-Hsiang Hsu, Kung-Chao Chang, Ming-Shi Chang. Interleukin-24 protects against liver injury in mouse models. EBioMedicine 2021; 64: 103213 doi: 10.1016/j.ebiom.2021.103213
|
| 164 |
Fa-Da Wang, Jing Zhou, En-Qiang Chen. Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.787748
|
| 165 |
Dishen Chen, Thanh H. Le, Haleh Shahidipour, Scott A. Read, Golo Ahlenstiel. The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression. Cells 2019; 8(11): 1324 doi: 10.3390/cells8111324
|
| 166 |
Joseph George, Mutsumi Tsuchishima, Mikihiro Tsutsumi. Metabolism of N-nitrosodimethylamine, methylation of
macromolecules, and development of hepatic fibrosis in rodent models. Journal of Molecular Medicine 2020; 98(9): 1203 doi: 10.1007/s00109-020-01950-7
|
| 167 |
Federico Armando, Federico Mazzola, Luca Ferrari, Attilio Corradi. An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?. Veterinary Sciences 2022; 10(1): 19 doi: 10.3390/vetsci10010019
|
| 168 |
Gholampour Firouzeh, Abbasi Susan, Karimi Zeinab. Quercetin prevents rats from type 1 diabetic liver damage by inhibiting TGF-ꞵ/apelin gene expression. Current Research in Pharmacology and Drug Discovery 2024; 7: 100201 doi: 10.1016/j.crphar.2024.100201
|
| 169 |
Hong Li, Tingli Liu, Yongchun Yang, William C. Cho, Robin J. Flynn, Majid Fasihi Harandi, Houhui Song, Xuenong Luo, Yadong Zheng. Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy. Genes & Diseases 2023; 10(4): 1457 doi: 10.1016/j.gendis.2022.08.013
|
| 170 |
Klaudia Sztolsztener, Karolina Konstantynowicz-Nowicka, Anna Pędzińska-Betiuk, Adrian Chabowski. Concentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media. Cells 2023; 12(18): 2243 doi: 10.3390/cells12182243
|
| 171 |
Anna Egresi, Anna Blázovics, Gabriella Lengyel, Adrienn Gréta Tóth, Barbara Csongrády, Zsuzsanna Jakab, Krisztina Hagymási. Redox Homeostasis and Non-Invasive Assessment of Significant Liver Fibrosis by Shear Wave Elastography. Diagnostics 2024; 14(17): 1945 doi: 10.3390/diagnostics14171945
|
| 172 |
Md. Abdullah Al Mamun, Md. Faruk, Md. Mizanur Rahman, Kamrun Nahar, Fariha Kabir, Md Ashraful Alam, Nusrat Subhan. High Carbohydrate High Fat Diet Induced Hepatic Steatosis and Dyslipidemia Were Ameliorated byPsidium guajavaLeaf Powder Supplementation in Rats. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/1897237
|
| 173 |
Büsra Öztürk Akcora, Eshwari Dathathri, Ana Ortiz‐Perez, Alexandras Vassilios Gabriël, Gert Storm, Jai Prakash, Ruchi Bansal.
TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis
in vivo
. The FASEB Journal 2019; 33(8): 9466 doi: 10.1096/fj.201900215RR
|
| 174 |
I. A. Karabak, D. Yu. Lobzin, V. E. Karev. Clinical and immunomorphological predictors of the adverse course of chronic hepatitis C. Journal Infectology 2020; 12(2): 79 doi: 10.22625/2072-6732-2020-12-2-79-87
|
| 175 |
Guo-wen Li, Xue-feng Yang, Nian Fu, Yan Ou-yang, Kai Qing. Relation Between Cellular Senescence and Liver Diseases. Chinese Medical Sciences Journal 2016; 31(2): 121 doi: 10.1016/S1001-9294(16)30036-0
|
| 176 |
Md Ashraful Alam, Abu Taher Sagor, Nabila Tabassum, Anayt Ulla, Manik Chandra Shill, Ghazi Muhammad Sayedur Rahman, Hemayet Hossain, Hasan Mahmud Reza. Caffeic acid rich Citrus macroptera peel powder supplementation prevented oxidative stress, fibrosis and hepatic damage in CCl4 treated rats. Clinical Phytoscience 2018; 4(1) doi: 10.1186/s40816-018-0074-y
|
| 177 |
Fang Hu, Xingcheng Zhou, Qianqian Peng, Lu Ma. Suppressed Histone H3 Lysine 18 Acetylation Is Involved in Arsenic-Induced Liver Fibrosis in Rats by Triggering the Dedifferentiation of Liver Sinusoidal Endothelial Cells. Toxics 2023; 11(11): 928 doi: 10.3390/toxics11110928
|
| 178 |
Bingying Wang, Huan Yang, Yinyin Fan, Yong Yang, Wei Cao, Yanwei Jia, Ying Cao, Kangyun Sun, Zhi Pang, Hong Du. 3-Methyladenine ameliorates liver fibrosis through autophagy regulated by the NF-κB signaling pathways on hepatic stellate cell. Oncotarget 2017; 8(64): 107603 doi: 10.18632/oncotarget.22539
|
| 179 |
Sabrina Campisano, Anabela La Colla, Stella M. Echarte, Andrea N. Chisari. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. Nutrition Research Reviews 2019; 32(1): 128 doi: 10.1017/S0954422418000239
|
| 180 |
Xia Yao, Jing Wang, Jiajing Zhu, Xiaoli Rong. The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis. Stem Cell Research & Therapy 2020; 11(1) doi: 10.1186/s13287-020-01891-5
|
| 181 |
Brenda de Oliveira da Silva, Letícia Ferrreira Ramos, Karen C. M. Moraes. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis. Cell Biology International 2017; 41(9): 946 doi: 10.1002/cbin.10790
|
| 182 |
Diane Wong, Friedeborg Seitz, Verena Bauer, Thomas Giessmann, Friedrich Schulze. Safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 685509, a soluble guanylyl cyclase activator, in healthy volunteers: Results from two randomized controlled trials. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(10): 8101 doi: 10.1007/s00210-024-03165-w
|
| 183 |
|
| 184 |
Gerhard Rogler. New Therapeutic Avenues for Treatment of Fibrosis: Can We Learn from Other Diseases?. Digestive Diseases 2014; 32(Suppl. 1): 39 doi: 10.1159/000367825
|
| 185 |
Sara Abouelasrar Salama, Muriel Lavie, Mieke De Buck, Jo Van Damme, Sofie Struyf. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection. Cytokine & Growth Factor Reviews 2019; 50: 29 doi: 10.1016/j.cytogfr.2019.10.006
|
| 186 |
Merve Özel, Mevlut Baskol, Hilal Akalın, Gulden Baskol. Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial–Mesenchymal Transition (EMT). Cell Biochemistry and Biophysics 2021; 79(2): 349 doi: 10.1007/s12013-021-00974-1
|
| 187 |
Rachel S Goodman, Lavanya Mittal, Eva Rawlings Parker. Public Health Risks, Dermatological Manifestations, and Environmental Justice Associated With Vinyl Chloride Exposure: Narrative Review. JMIR Dermatology 2023; 6: e48998 doi: 10.2196/48998
|
| 188 |
Mei Takano, Hiroshi Watanabe, Shota Toda, Kento Nishida, Tadashi Imafuku, Yuki Minayoshi, Takehiro Nakano, Hitoshi Maeda, Toru Maruyama. Therapeutic Effects of Albumin-Fused BMP7 on 2 Experimental Models of Liver Fibrosis. Biological and Pharmaceutical Bulletin 2023; 46(10): 1421 doi: 10.1248/bpb.b23-00254
|
| 189 |
Nadezhda Bakalenko, Evdokiya Kuznetsova, Anna Malashicheva. The Complex Interplay of TGF-β and Notch Signaling in the Pathogenesis of Fibrosis. International Journal of Molecular Sciences 2024; 25(19): 10803 doi: 10.3390/ijms251910803
|
| 190 |
Gang Cao, Ruyi Zhu, Ting Jiang, Dongxin Tang, Hiu Yee Kwan, Tao Su. Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling. Phytomedicine 2019; 63: 153055 doi: 10.1016/j.phymed.2019.153055
|
| 191 |
Meng-chen Qin, Jun-jie Li, Yan-tao Zheng, Yun-jia Li, Yu-xue Zhang, Rou-xuan Ou, Wei-yi He, Jia-min Zhao, Su-tong Liu, Ming-hao Liu, Hai-yan Lin, Lei Gao. Naringin ameliorates liver fibrosis in zebrafish by modulating IDO1-mediated lipid metabolism and inflammatory infiltration. Food & Function 2023; 14(23): 10347 doi: 10.1039/D3FO03858K
|
| 192 |
Xuan Zhang, Ming-Gen Hu, Ke Pan, Chong-Hui Li, Rong Liu, Shimon Slavin. 3D Spheroid Culture Enhances the Expression of Antifibrotic Factors in Human Adipose‐Derived MSCs and Improves Their Therapeutic Effects on Hepatic Fibrosis. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/4626073
|
| 193 |
Kunj Vyas, Mayur M Patel. Insights on drug and gene delivery systems in liver fibrosis. Asian Journal of Pharmaceutical Sciences 2023; 18(2): 100779 doi: 10.1016/j.ajps.2023.100779
|
| 194 |
Sheng Wang, Chen Shuai, Songsen Gao, Jia Jiang, Jiajie Luan, Xiongwen Lv. Chemokine CXCL14 acts as a potential genetic target for liver fibrosis. International Immunopharmacology 2020; 89: 107067 doi: 10.1016/j.intimp.2020.107067
|
| 195 |
Julia Maroto-García, Ana Moreno-Álvarez, María P. Sanz de Pedro, Antonio Buño-Soto, Álvaro González. Biomarcadores séricos para la evaluación de la fibrosis hepática. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2024; 5(2): 131 doi: 10.1515/almed-2023-0172
|
| 196 |
Yufei Yan, Jiefei Zeng, Linhao Xing, Changyong Li. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation. Biomedicines 2021; 9(8): 1014 doi: 10.3390/biomedicines9081014
|
| 197 |
Haibing Gao, Xiangmei Wang, Huaxi Ma, Shenglong Lin, Dongqing Zhang, Wenjun Wu, Ziyuan Liao, Mengyun Chen, Hanhui Ye, Qin Li, Minghua Lin, Dongliang Li. LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-25738-6
|
| 198 |
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Options of non-invasive assessment of liver fibrosis based on the clinical data. Orvosi Hetilap 2015; 156(2): 43 doi: 10.1556/OH.2015.30069
|
| 199 |
Xianyao Wang, Huizhen Wang, Junhou Lu, Zhanhui Feng, Zhongshan Liu, Hailiang Song, Heng Wang, Yanhua Zhou, Jianwei Xu. Erythropoietin-Modified Mesenchymal Stem Cells Enhance Anti-fibrosis Efficacy in Mouse Liver Fibrosis Model. Tissue Engineering and Regenerative Medicine 2020; 17(5): 683 doi: 10.1007/s13770-020-00276-2
|
| 200 |
Lipika Salaye, Ielizaveta Bychkova, Sandy Sink, Alexander J. Kovalic, Manish S. Bharadwaj, Felipe Lorenzo, Shalini Jain, Alexandria V. Harrison, Ashley T. Davis, Katherine Turnbull, Nuwan T. Meegalla, Soh-hyun Lee, Robert Cooksey, George L. Donati, Kylie Kavanagh, Herbert L. Bonkovsky, Donald A. McClain. A Low Iron Diet Protects from Steatohepatitis in a Mouse Model. Nutrients 2019; 11(9): 2172 doi: 10.3390/nu11092172
|
| 201 |
Yang Li, Jiantao Dong, Ye Zhou, Xueshuai Ye, Ziqi Cai, Xueqian Zhang, Li Shen, Mengya Zhang, Wanxing Zhang, Jianhui Cai. Therapeutic effects of CXCL9-overexpressing human umbilical cord mesenchymal stem cells on liver fibrosis in rats. Biochemical and Biophysical Research Communications 2021; 584: 87 doi: 10.1016/j.bbrc.2021.10.078
|
| 202 |
Roberta Sferra, Antonella Vetuschi, Simona Pompili, Eugenio Gaudio, Silvia Speca, Giovanni Latella. Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis. Pathology - Research and Practice 2017; 213(1): 58 doi: 10.1016/j.prp.2016.11.004
|
| 203 |
Plekhova N.G., Korolev D.V., Shumatov V.B., Voroshilov A.D., Lisitsa G.T., Bystritskaya A.S.. STUDY OF ACUTE AND CHRONIC TOXICITY A DRUG FOR PHARMACO-CORRECTION OF LIVER FIBROSIS. Bulletin "Biomedicine and sociology" 2023; : 58 doi: 10.26787/nydha-2618-8783-2023-8-4-58-66
|
| 204 |
Xuanyan Cai, Jiajia Wang, Jincheng Wang, Qian Zhou, Bo Yang, Qiaojun He, Qinjie Weng. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy. Pharmacological Research 2020; 155: 104720 doi: 10.1016/j.phrs.2020.104720
|
| 205 |
Tianyu Niu, Weixiao Niu, Yunyang Bao, Ting Liu, Danqing Song, Yinghong Li, Hongwei He. Discovery of Matrinic Thiadiazole Derivatives as a Novel Family of Anti-Liver Fibrosis Agents via Repression of the TGFβ/Smad Pathway. Molecules 2018; 23(7): 1644 doi: 10.3390/molecules23071644
|
| 206 |
Jae Hyun Han, Ok-Hee Kim, Sang Chul Lee, Kee-Hwan Kim, Jung Hyun Park, Jae Im Lee, Kyung Hee Lee, Ha-Eun Hong, Haeyeon Seo, Ho Joong Choi, Ji Hyeon Ju, Say-June Kim. A Novel Hepatic Anti-Fibrotic Strategy Utilizing the Secretome Released from Etanercept-Synthesizing Adipose-Derived Stem Cells. International Journal of Molecular Sciences 2019; 20(24): 6302 doi: 10.3390/ijms20246302
|
| 207 |
M. I. Pykov, N. E. Kuzmina, N. M. Rostovtsev. Shear wave elastography options in the integrated assessment of liver parenchyma in children. Meditsinskiy sovet = Medical Council 2022; (12): 146 doi: 10.21518/2079-701X-2022-16-12-146-151
|
| 208 |
A. T. Fiyas, N. F. Vasilevskaya, E. F. Pishchyk. LIVER FIBROSIS: MECHANISMS AND THERAPY APPROACHES. Hepatology and Gastroenterology 2019; 3(2): 127 doi: 10.25298/2616-5546-2019-3-2-127-134
|
| 209 |
Yu Huang, Xiangxue Fan, Ran Tao, Qiqin Song, Likui Wang, Hongyue Zhang, Hongyan Kong, Jiaquan Huang. Effect of miR‐182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway. Journal of Cellular Physiology 2018; 233(10): 6693 doi: 10.1002/jcp.26469
|
| 210 |
Yi Zhang, Hui Miao, Huida Guan, Changhong Wang, Zhengtao Wang, Lili Ji. Long-term diosbulbin B treatment induced liver fibrosis in mice. Chemico-Biological Interactions 2019; 298: 15 doi: 10.1016/j.cbi.2018.10.015
|
| 211 |
Baris Yilmaz, Huseyin Kayadibi, Abdullah O. Yeniova, Huseyin Koseoglu, Zahide Simsek. The age, bilirubin and albumin (ABA) index: a novel noninvasive index for predicting liver fibrosis in patients with chronic hepatitis C infection. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e290 doi: 10.1097/MEG.0000000000002038
|
| 212 |
Eric J. Lawitz, Thomas Reiberger, Jörn M. Schattenberg, Corinna Schoelch, Harvey O. Coxson, Diane Wong, Judith Ertle. Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib study. Hepatology Communications 2023; 7(11) doi: 10.1097/HC9.0000000000000276
|
| 213 |
L. V. Tarasova, V. N. Diomidova, N. V. Tolmacheva, Yu. V. Tsyganova, A. L. Ivanova, J. V. Maslova, E. V. Barsukova. Correlation of secreted frizzled related protein-4 adipokin expression and expression of fatty liver changes under the conditions of a chronic experiment. Experimental and Clinical Gastroenterology 2021; 1(5): 44 doi: 10.31146/1682-8658-ecg-189-5-44-48
|
| 214 |
Kristina Duspara, Kristina Bojanic, Josipa Ivanusic Pejic, Lucija Kuna, Tea Omanovic Kolaric, Vjera Nincevic, Robert Smolic, Aleksandar Vcev, Marija Glasnovic, Ines Bilic Curcic, Martina Smolic. Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00065
|
| 215 |
Karthik Shree Harini, Devaraj Ezhilarasan. Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress. Journal of Drug Delivery Science and Technology 2024; 93: 105467 doi: 10.1016/j.jddst.2024.105467
|
| 216 |
Marta Costas-Rodríguez, Thibaut Van Acker, Agustina A. M. B. Hastuti, Lindsey Devisscher, Sanne Van Campenhout, Hans Van Vlierberghe, Frank Vanhaecke. Laser ablation-inductively coupled plasma-mass spectrometry for quantitative mapping of the copper distribution in liver tissue sections from mice with liver disease induced by common bile duct ligation. Journal of Analytical Atomic Spectrometry 2017; 32(9): 1805 doi: 10.1039/C7JA00134G
|
| 217 |
Dan-dan Xu, Xiao-feng Li, Yu-huan Li, Yan-hui Liu, Cheng Huang, Xiao-ming Meng, Jun Li. TIPE2 attenuates liver fibrosis by reversing the activated hepatic stellate cells. Biochemical and Biophysical Research Communications 2018; 498(1): 199 doi: 10.1016/j.bbrc.2017.11.178
|
| 218 |
Pratima Dibba, Andrew A. Li, George Cholankeril, Umair Iqbal, Chiranjeevi Gadiparthi, Muhammad Ali Khan, Donghee Kim, Aijaz Ahmed. The Role of Cannabinoids in the Setting of Cirrhosis. Medicines 2018; 5(2): 52 doi: 10.3390/medicines5020052
|
| 219 |
Sarah Y. Neshat, Victor M. Quiroz, Yuanjia Wang, Sebastian Tamayo, Joshua C. Doloff. Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions. International Journal of Molecular Sciences 2021; 22(13): 6777 doi: 10.3390/ijms22136777
|
| 220 |
Ming-ming Ni, Tao Xu, Ya-rui Wang, Ying-hua He, Qun Zhou, Cheng Huang, Xiao-ming Meng, Jun Li. Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cells. Journal of Physiology and Biochemistry 2016; 72(1): 9 doi: 10.1007/s13105-015-0452-6
|
| 221 |
Li Li, Jianghua Ran, Lan Li, Gang Chen, Shengning Zhang, Yingjia Wang. Gli3 is a novel downstream target of miR‑200a with an anti‑fibrotic role for progression of liver fibrosis in�vivo and in�vitro. Molecular Medicine Reports 2020; doi: 10.3892/mmr.2020.10997
|
| 222 |
Alessandra Breschi, Manuel Muñoz-Aguirre, Valentin Wucher, Carrie A. Davis, Diego Garrido-Martín, Sarah Djebali, Jesse Gillis, Dmitri D. Pervouchine, Anna Vlasova, Alexander Dobin, Chris Zaleski, Jorg Drenkow, Cassidy Danyko, Alexandra Scavelli, Ferran Reverter, Michael P. Snyder, Thomas R. Gingeras, Roderic Guigó. A limited set of transcriptional programs define major cell types. Genome Research 2020; 30(7): 1047 doi: 10.1101/gr.263186.120
|
| 223 |
Zeinab Abedian, Sadegh Fattahi, Roghayeh Pourbagher, Sahar Edrisi, Amrollah Mostafazadeh. Sustained small and intermediate size proteins expression in phorbol 12-myristate 13-acetate/ionomycine prolonged stimulated human fibroblasts. Asian Pacific Journal of Tropical Biomedicine 2017; 7(5): 432 doi: 10.1016/j.apjtb.2017.01.015
|
| 224 |
Liu-Hong Shen, Lei Fan, Yue Zhang, Ying-Kun Zhu, Xiao-Lan Zong, Guang-Neng Peng, Sui-Zhong Cao. Protective Effect and Mechanism of Placenta Extract on Liver. Nutrients 2022; 14(23): 5071 doi: 10.3390/nu14235071
|
| 225 |
N. A. Efremova, V. A. Greshnyakova, L. G. Goryacheva. Modern concepts on pathogenetic mechanisms of liver fibrosis. Journal Infectology 2023; 15(1): 16 doi: 10.22625/2072-6732-2023-15-1-16-24
|
| 226 |
Jung Yoon Pyo, Sung Soo Ahn, Lucy Eunju Lee, Gwang-mu Choi, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee. The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases. Clinics 2021; 76: e2501 doi: 10.6061/clinics/2021/e2501
|
| 227 |
Yu Xiong, Jinyuan Hu, Chen Xuan, Jiayu Tian, Kaiyue Tan, Zhiwei Chen, Yan Luo, Xuqin Du, Junxiong Cheng, Lanyue Zhang, Wenfu Cao. Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl4-induced liver fibrosis in rats. Chinese Medicine 2021; 16(1) doi: 10.1186/s13020-021-00552-w
|
| 228 |
Wenbin Hong, Tianyichen Xiao, Gang Lin, Changqin Liu, Hailong Li, Yunlong Li, Hongyu Hu, Siqi Wu, Songqing Wang, Zhijian Liang, Tianwei Lin, Jie Liu, Xueqin Chen. Structure-based design and synthesis of anti-fibrotic compounds derived from para-positioned 3,4,5-trisubstituted benzene. Bioorganic Chemistry 2024; 144: 107113 doi: 10.1016/j.bioorg.2024.107113
|
| 229 |
Daphne Pinheiro, Luana Leirós, Juliana Barbosa Torreão Dáu, Ana Carolina Stumbo, Alessandra Alves Thole, Erika Afonso Costa Cortez, Carlos Alberto Mandarim-de-Lacerda, Lais de Carvalho, Simone Nunes de Carvalho, Maria Cristina Vinci. Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice. PLOS ONE 2017; 12(11): e0187970 doi: 10.1371/journal.pone.0187970
|
| 230 |
Lourdes Rodríguez-Fragoso, Anahí Rodríguez-López, Janet Sánchez-Quevedo. Animal Models and Experimental Research in Medicine. 2023; doi: 10.5772/intechopen.106219
|
| 231 |
Maryam Aghadi, Ramy Elgendy, Essam M. Abdelalim. Loss of FOXA2 induces ER stress and hepatic steatosis and alters developmental gene expression in human iPSC-derived hepatocytes. Cell Death & Disease 2022; 13(8) doi: 10.1038/s41419-022-05158-0
|
| 232 |
Quanquan Cao, Hongying Shan, Ju Zhao, Jinhe Deng, Man Xu, Hao Kang, Tong Li, Ye Zhao, Haifeng Liu, Jun Jiang. Liver fibrosis in fish research: From an immunological perspective. Fish & Shellfish Immunology 2023; 139: 108885 doi: 10.1016/j.fsi.2023.108885
|
| 233 |
Chun-Hung Chiu, Chun-Chao Chang, Shiang-Ting Lin, Charng-Cherng Chyau, Robert Peng. Improved Hepatoprotective Effect of Liposome-Encapsulated Astaxanthin in Lipopolysaccharide-Induced Acute Hepatotoxicity. International Journal of Molecular Sciences 2016; 17(7): 1128 doi: 10.3390/ijms17071128
|
| 234 |
Gülsüm Özlem Elpek. Neuropilins and liver. World Journal of Gastroenterology 2015; 21(23): 7065-7073 doi: 10.3748/wjg.v21.i23.7065
|
| 235 |
Qiaozhu Su, Virender Kumar, Neetu Sud, Ram I. Mahato. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Advanced Drug Delivery Reviews 2018; 129: 54 doi: 10.1016/j.addr.2018.01.009
|
| 236 |
Fang Yang, Guo-Xun Chen. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis. World Journal of Gastroenterology 2018; 24(36): 4132-4151 doi: 10.3748/wjg.v24.i36.4132
|
| 237 |
Beomseok Son, TaeWoo Kwon, Sungmin Lee, IkJoon Han, Wanyeon Kim, HyeSook Youn, BuHyun Youn. CYP2E1 regulates the development of radiation-induced pulmonary fibrosis via ER stress- and ROS-dependent mechanisms. American Journal of Physiology-Lung Cellular and Molecular Physiology 2017; 313(5): L916 doi: 10.1152/ajplung.00144.2017
|
| 238 |
Joselyn Allen, Jingtao Zhang, Michael D. Quickel, Mary Kennett, Andrew D. Patterson, Pamela A. Hankey-Giblin. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model. Journal of Proteome Research 2018; 17(9): 3268 doi: 10.1021/acs.jproteome.8b00379
|
| 239 |
Magisetty Obulesu. Turmeric and Curcumin for Neurodegenerative Diseases. 2021; : 139 doi: 10.1016/B978-0-12-822448-9.00004-2
|
| 240 |
Yutong Dong, Yuwei Liu, Xu Liu, Heming Ma, Yahui Liu, Guoyue Lv, Junqi Niu. Multi‐omics profiling of primary hepatic stellate cells from advanced liver fibrosis patients reveals distinctive molecular signatures. Journal of Gastroenterology and Hepatology 2023; 38(8): 1416 doi: 10.1111/jgh.16221
|
| 241 |
Elsayed A. Elmorsy, Sameh Saber, Ahmed Y. Kira, Abdullah Alghasham, Mohamed R. Abdel-Hamed, Maha M. Amer, Enas A. Mohamed, A AlSalloom A., Abdullah S. Alkhamiss, Rabab S. Hamad, Mustafa Ahmed Abdel-Reheim, Abousree T. Ellethy, Hossam A. Elsisi, Mansour Alsharidah, Sahar R. Elghandour, Tayseer Elnawawy, Rasha Abdelhady. Hedgehog signaling is a promising target for the treatment of hepatic fibrogenesis: a new management strategy using itraconazole-loaded nanoparticles. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1377980
|
| 242 |
Mariia Zadorozhna, Sante Di Gioia, Massimo Conese, Domenica Mangieri. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment. Molecular Biology Reports 2020; 47(3): 2279 doi: 10.1007/s11033-020-05290-0
|
| 243 |
Haiying Dong, Hongyan Guo, Yini Liang, Xing Wang, Yingcai Niu. Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activationin vitro. Free Radical Research 2017; 51(2): 167 doi: 10.1080/10715762.2017.1290233
|
| 244 |
Ratna Puspita, Ahmad Aulia Jusuf, Radiana Dhewayani Antarianto, Imelda Rosalyn Sianipar. A systematic review of the anti-inflammatory and anti-fibrotic potential of human umbilical cord mesenchymal stem cells-derived exosomes in experimental models of liver regeneration. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09929-0
|
| 245 |
Amanda K. Jones, Hongxing Chen, Khing Jow Ng, Jorge Villalona, Mark McHugh, Svetlana Zeveleva, James Wilks, Klaus Brilisauer, Tom Bretschneider, Hu Sheng Qian, Ryan M. Fryer. Soluble Guanylyl Cyclase Activator BI 685509 Reduces Portal Hypertension and Portosystemic Shunting in a Rat Thioacetamide-Induced Cirrhosis Model. Journal of Pharmacology and Experimental Therapeutics 2023; 386(1): 70 doi: 10.1124/jpet.122.001532
|
| 246 |
Guangrui Chen, Jian Li, Huimeng Liu, Huiyu Zhou, Mingqiu Liu, Di Liang, Zhiyun Meng, Hui Gan, Zhuona Wu, Xiaoxia Zhu, Peng Han, Taoyun Liu, Ruolan Gu, Shuchen Liu, Guifang Dou. Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation. Molecules 2023; 28(2): 753 doi: 10.3390/molecules28020753
|
| 247 |
E. I. Lebedeva, O. D. Myadelets. CELLULAR AND MOLECULAR MECHANISMS OF LIVER FIBROGENESIS. Hepatology and Gastroenterology 2019; 3(2): 119 doi: 10.25298/2616-5546-2019-3-2-119-126
|
| 248 |
Jelske N. van der Veen, Susanne Lingrell, Xia Gao, Abhijit Takawale, Zamaneh Kassiri, Dennis E. Vance, René L. Jacobs. Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase. Journal of Lipid Research 2017; 58(4): 656 doi: 10.1194/jlr.M070631
|
| 249 |
Rafael Cierpka, Ralf Weiskirchen, Anastasia Asimakopoulos. Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation. Cells 2021; 10(9): 2184 doi: 10.3390/cells10092184
|
| 250 |
Ricardo Moreno Traspas, Tze Shin Teoh, Pui-Mun Wong, Michael Maier, Crystal Y. Chia, Kenneth Lay, Nur Ain Ali, Austin Larson, Fuad Al Mutairi, Nouriya Abbas Al-Sannaa, Eissa Ali Faqeih, Majid Alfadhel, Huma Arshad Cheema, Juliette Dupont, Stéphane Bézieau, Bertrand Isidor, Dorrain Yanwen Low, Yulan Wang, Grace Tan, Poh San Lai, Hugues Piloquet, Madeleine Joubert, Hulya Kayserili, Kimberly A. Kripps, Shareef A. Nahas, Eric P. Wartchow, Mikako Warren, Gandham SriLakshmi Bhavani, Majed Dasouki, Renata Sandoval, Elisa Carvalho, Luiza Ramos, Gilda Porta, Bin Wu, Harsha Prasada Lashkari, Badr AlSaleem, Raeda M. BaAbbad, Anabela Natália Abreu Ferrão, Vasiliki Karageorgou, Natalia Ordonez-Herrera, Suliman Khan, Peter Bauer, Benjamin Cogne, Aida M. Bertoli-Avella, Marie Vincent, Katta Mohan Girisha, Bruno Reversade. Loss of FOCAD, operating via the SKI messenger RNA surveillance pathway, causes a pediatric syndrome with liver cirrhosis. Nature Genetics 2022; 54(8): 1214 doi: 10.1038/s41588-022-01120-0
|
| 251 |
Furqan Shafqat, Shafeeq Ur Rehman, Muhammad Sajjad Khan, Kamal Niaz. Encyclopedia of Toxicology. 2024; : 897 doi: 10.1016/B978-0-12-824315-2.00138-X
|
| 252 |
Chun-Hung Liu, Kun-Ming Chan, Tsaiyu Chiang, Jia-Yu Liu, Guann-Gen Chern, Fu-Fei Hsu, Yu-Hsuan Wu, Ya-Chi Liu, Yunching Chen. Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis. Molecular Pharmaceutics 2016; 13(7): 2253 doi: 10.1021/acs.molpharmaceut.5b00913
|
| 253 |
Mengping Huang, Xin Lu, Xiaofeng Wang, Jian Shu. Diffusion tensor imaging quantifying the severity of chronic hepatitis in rats. BMC Medical Imaging 2020; 20(1) doi: 10.1186/s12880-020-00466-3
|
| 254 |
Burkhard Kleuser. Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease. International Journal of Molecular Sciences 2018; 19(3): 722 doi: 10.3390/ijms19030722
|
| 255 |
Md Mizanur Rahman, Awale Yousuf Muse, D.M. Isha Olive Khan, Ismaile Hussein Ahmed, Nusrat Subhan, Hasan Mahmud Reza, Md Ashraful Alam, Lutfun Nahar, Satyajit Dey Sarker. Apocynin prevented inflammation and oxidative stress in carbon tetra chloride induced hepatic dysfunction in rats. Biomedicine & Pharmacotherapy 2017; 92: 421 doi: 10.1016/j.biopha.2017.05.101
|
| 256 |
Qing Li, Jilong Wang, Jiahui Lv, Dengyu Liu, Suyu Xiao, Jingquan Mo, Zuochao Lu, Ran Qiu, Caiqi Li, Lili Tang, Shanshan He, Zeli Tang, Qiuchen Cheng, Tingzheng Zhan. Total flavonoids of litchi Seed alleviates schistosomiasis liver fibrosis in mice by suppressing hepatic stellate cells activation and modulating the gut microbiomes. Biomedicine & Pharmacotherapy 2024; 178: 117240 doi: 10.1016/j.biopha.2024.117240
|
| 257 |
Yongdae Yoon, Seong Chan Gong, Moon Young Kim, Soon Koo Baik, Ju-Eun Hong, Ki-Jong Rhee, Hoon Ryu, Young Woo Eom. Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages. Cells 2023; 12(21): 2514 doi: 10.3390/cells12212514
|
| 258 |
Nancy Magee, An Zou, Yuxia Zhang. Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/5170402
|
| 259 |
Dmitry Victorovich Garbuzenko. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis . World Journal of Clinical Cases 2022; 10(12): 3662-3676 doi: 10.12998/wjcc.v10.i12.3662
|
| 260 |
Haojie Wang, Yumei Liu, Dongmei Wang, Yaolu Xu, Ruiqi Dong, Yuxiang Yang, Qiongxia Lv, Xiaoguang Chen, Ziqiang Zhang. The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases. Cells 2019; 8(12): 1597 doi: 10.3390/cells8121597
|
| 261 |
Lindolfo da Silva Meirelles, Renan Fava Marson, Maria Inês Gonzalez Solari, Nance Beyer Nardi. Are Liver Pericytes Just Precursors of Myofibroblasts in Hepatic Diseases? Insights from the Crosstalk between Perivascular and Inflammatory Cells in Liver Injury and Repair. Cells 2020; 9(1): 188 doi: 10.3390/cells9010188
|
| 262 |
Alfonsina Milito, Mariarita Brancaccio, Giuseppe D’Argenio, Immacolata Castellano. Natural Sulfur-Containing Compounds: An Alternative Therapeutic Strategy against Liver Fibrosis. Cells 2019; 8(11): 1356 doi: 10.3390/cells8111356
|
| 263 |
Salwa A. Ibrahim, Mervat Z. Mohamed, Nashwa F. El-Tahawy, Aly M. Abdelrahman. Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats. Canadian Journal of Physiology and Pharmacology 2021; 99(3): 313 doi: 10.1139/cjpp-2020-0159
|
| 264 |
Yan Wang, Kun Shi, Jiyuan Tu, Chang Ke, Niping Chen, Bo Wang, Yanju Liu, Zhongshi Zhou. Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism. Molecules 2023; 28(14): 5504 doi: 10.3390/molecules28145504
|
| 265 |
Shu Dong, Fei-fei Cai, Qi-long Chen, Ya-nan Song, Yang Sun, Bin Wei, Xiao-yan Li, Yi-yang Hu, Ping Liu, Shi-bing Su. Chinese herbal formula Fuzheng Huayu alleviates CCl4-induced liver fibrosis in rats: a transcriptomic and proteomic analysis. Acta Pharmacologica Sinica 2018; 39(6): 930 doi: 10.1038/aps.2017.150
|
| 266 |
Özlem Akdoğan, Ayşegül Atak Yücel, Zeynep Gök Sargin, Cemile Sönmez, Güldal Esendağli Yilmaz, Seren Özenirler. Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. Journal of Clinical and Experimental Hepatology 2019; 9(1): 29 doi: 10.1016/j.jceh.2018.02.001
|
| 267 |
Ju‐Seop Kang, Min‐Ho Lee. Liver Cirrhosis - Update and Current Challenges. 2017; doi: 10.5772/intechopen.68317
|
| 268 |
Wenzhang Dai, Qin Qin, Zhiyong Li, Li Lin, Ruisheng Li, Zhie Fang, Yanzhong Han, Wenqing Mu, Lutong Ren, Tingting Liu, Xiaoyan Zhan, Xiaohe Xiao, Zhaofang Bai. Curdione and Schisandrin C Synergistically Reverse Hepatic Fibrosis via Modulating the TGF-β Pathway and Inhibiting Oxidative Stress. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.763864
|
| 269 |
Mostafa M. Salah, Ahmed A. Ashour, Tamer M. Abdelghany, Abdel-Aziz H. Abdel-Aziz, Salama A. Salama. Pirfenidone alleviates concanavalin A-induced liver fibrosis in mice. Life Sciences 2019; 239: 116982 doi: 10.1016/j.lfs.2019.116982
|
| 270 |
Liwei Guo, Yong An, Xu Huang, Wenhua Liu, Fangfang Chen, Yuchen Fan, Shuai Gao, Liyan Han, Kai Wang. A Mendelian randomization study on the causal effects of cigarette smoking on liver fibrosis and cirrhosis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1390049
|
| 271 |
Piotr Czekaj, Mateusz Król, Łukasz Limanówka, Marcin Michalik, Katarzyna Lorek, Roberto Gramignoli. Assessment of animal experimental models of toxic liver injury in the context of their potential application as preclinical models for cell therapy. European Journal of Pharmacology 2019; 861: 172597 doi: 10.1016/j.ejphar.2019.172597
|
| 272 |
Weiping Niu, Mei Zhu, Minghua Wang, Guoning Zhang, Chenghong Zheng, Yunyang Bao, Yiming Li, Na Zhang, Juxian Wang, Hongwei He, Yucheng Wang. Discovery and development of benzene sulfonamide derivatives as anti-hepatic fibrosis agents. Bioorganic & Medicinal Chemistry Letters 2023; 88: 129290 doi: 10.1016/j.bmcl.2023.129290
|
| 273 |
Yuanmei Bai, Haimei Wu, Lijie Zheng, Yuhuan Xie, Feifan Liu, Yan Wan, Qiongchao Li, Peixin Guo. Mechanisms of Yajieshaba in the treatment of liver fibrosis through the Keap1-Nrf2 signaling pathway. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1124015
|